drugset / Trial / NCT07583147

Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage.

NCT07583147

Phase 2 Not yet recruiting 117 enrolled University Hospital, Toulouse
NaSingle-groupOpen-labelBasic science

Summary

In this prospective, multicenter study of patients with acute spontaneous supratentorial Intracerebral Hemorrhage (ICH), each participant will have a standardized multimodal evaluation of neuroinflammation at 10 (±2) days after onset including translocator protein 18 kDa (TSPO) positron emission tomography (PET) using 18F-DPA-714 radioligand, BBB imaging using Dynamic contrast-enhanced (DCE)-MRI and a panel of pro-inflammatory and anti-inflammatory plasma biomarkers.

Timeline

Start
2026-06
Primary completion
2029-09
Completion
2029-12

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]DPA-714 Diagnostic / imaging agent